William Blair Analysts Lift Earnings Estimates for Encompass Health Co. (NYSE:EHC)

Encompass Health Co. (NYSE:EHC) – Stock analysts at William Blair boosted their Q1 2025 earnings estimates for Encompass Health in a research note issued to investors on Wednesday, April 24th. William Blair analyst J. Haase now expects that the company will earn $1.30 per share for the quarter, up from their prior estimate of $1.03. William Blair currently has a “Outperform” rating on the stock. The consensus estimate for Encompass Health’s current full-year earnings is $4.10 per share.

EHC has been the topic of a number of other reports. Mizuho increased their price target on shares of Encompass Health from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Thursday. Stephens reiterated an “overweight” rating and set a $85.00 price target on shares of Encompass Health in a research report on Tuesday, January 16th. Royal Bank of Canada reiterated an “outperform” rating and set a $83.00 price target on shares of Encompass Health in a research report on Friday, February 9th. Truist Financial raised their target price on shares of Encompass Health from $82.00 to $86.00 and gave the stock a “buy” rating in a report on Friday, February 9th. Finally, Barclays raised their target price on shares of Encompass Health from $101.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $88.13.

Encompass Health Trading Down 0.3 %

Shares of EHC opened at $82.47 on Monday. The firm’s 50 day simple moving average is $78.25 and its 200 day simple moving average is $70.96. The company has a market capitalization of $8.26 billion, a P/E ratio of 22.29, a P/E/G ratio of 1.50 and a beta of 0.94. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. Encompass Health has a 1-year low of $57.55 and a 1-year high of $85.84.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 earnings per share for the quarter, beating analysts’ consensus estimates of $0.93 by $0.19. The business had revenue of $1.32 billion for the quarter, compared to the consensus estimate of $1.27 billion. Encompass Health had a net margin of 7.60% and a return on equity of 18.01%. Encompass Health’s quarterly revenue was up 13.4% on a year-over-year basis. During the same period last year, the firm posted $0.88 earnings per share.

Encompass Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, April 15th. Investors of record on Monday, April 1st were issued a $0.15 dividend. This represents a $0.60 annualized dividend and a yield of 0.73%. The ex-dividend date of this dividend was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is currently 16.22%.

Hedge Funds Weigh In On Encompass Health

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Legacy Wealth Asset Management LLC raised its position in shares of Encompass Health by 1.5% in the 1st quarter. Legacy Wealth Asset Management LLC now owns 8,619 shares of the company’s stock worth $712,000 after purchasing an additional 130 shares during the last quarter. Benjamin Edwards Inc. increased its holdings in Encompass Health by 3.8% in the 4th quarter. Benjamin Edwards Inc. now owns 3,885 shares of the company’s stock worth $259,000 after buying an additional 142 shares in the last quarter. Horrell Capital Management Inc. increased its holdings in Encompass Health by 0.5% in the 1st quarter. Horrell Capital Management Inc. now owns 29,371 shares of the company’s stock worth $2,425,000 after buying an additional 147 shares in the last quarter. GAMMA Investing LLC increased its holdings in Encompass Health by 31.9% in the 1st quarter. GAMMA Investing LLC now owns 616 shares of the company’s stock worth $51,000 after buying an additional 149 shares in the last quarter. Finally, Treasurer of the State of North Carolina increased its holdings in Encompass Health by 0.5% in the 3rd quarter. Treasurer of the State of North Carolina now owns 48,339 shares of the company’s stock worth $3,246,000 after buying an additional 231 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.